Black Swan Sale

50% Off Elite

Get our most powerful screeners, new charting tools, and the fastest ad-
free experience at our best price ever. This deal may never happen again.

MEDP

Medpace Holdings Inc

Nov 26 • 04:00PM ET

606.60

-5.21 -0.85 %

Healthcare • Diagnostics & Research • USA • NASD

Peers: IQV CRL INCY LH ICON CTLT KOD FATE ALLO ONC

| Held by: IJH VTI VB XMHQ VBK VXF IBB MDY IWP IJK

Scroll to Statements

Index	-	P/E	42.42	EPS (ttm)	14.30	Insider Own	20.32%	Shs Outstand	28.10M	Perf Week	2.44%
Market Cap	17.09B	Forward P/E	36.49	EPS next Y	16.62	Insider Trans	-7.55%	Shs Float	22.44M	Perf Month	4.49%
Enterprise Value	16.95B	PEG	3.05	EPS next Q	4.19	Inst Own	87.45%	Short Float	6.14%	Perf Quarter	28.26%
Income	433.00M	P/S	7.25	EPS this Y	17.23%	Inst Trans	-8.83%	Short Ratio	4.40	Perf Half Y	104.21%
Sales	2.36B	P/B	58.04	EPS next Y	12.27%	ROA	22.57%	Short Interest	1.38M	Perf YTD	82.58%
Book/sh	10.45	P/C	59.88	EPS next 5Y	13.91%	ROE	73.70%	52W High	626.26 -3.14%	Perf Year	79.60%
Cash/sh	10.13	P/FCF	25.25	EPS past 3/5Y	37.94% 36.50%	ROIC	104.92%	52W Low	250.05 142.59%	Perf 3Y	177.11%
Dividend Est.	-	EV/EBITDA	31.64	Sales past 3/5Y	22.68% 19.62%	Gross Margin	29.90%	Volatility	3.16% 2.88%	Perf 5Y	389.35%
Dividend TTM	-	EV/Sales	7.19	EPS Y/Y TTM	23.92%	Oper. Margin	21.50%	ATR (14)	17.96	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	0.57	Sales Y/Y TTM	13.88%	Profit Margin	18.36%	RSI (14)	61.56	Recom	3.46
Dividend Gr. 3/5Y	- -	Current Ratio	0.57	EPS Q/Q	28.34%	SMA20	1.96%	Beta	1.42	Target Price	557.27
Payout	0.00%	Debt/Eq	0.49	Sales Q/Q	23.74%	SMA50	9.00%	Rel Volume	0.97	Prev Close	611.81
Employees	5900	LT Debt/Eq	0.41	Earnings	Oct 22 AMC	SMA200	50.25%	Avg Volume	313.19K	Price	606.60
IPO	Aug 11, 2016	Option/Short	Yes / Yes	EPS/Sales Surpr.	9.20% 2.95%	Trades		Volume	305,226	Change	-0.85%

Date	Action	Analyst	Rating Change	Price Target Change
Nov-13-25	Initiated	BMO Capital Markets	Market Perform	$600
Oct-02-25	Downgrade	Barclays	Equal Weight → Underweight	$425
Sep-03-25	Downgrade	Rothschild & Co Redburn	Buy → Neutral	$474
Jul-29-25	Downgrade	UBS	Neutral → Sell	$305
Jul-23-25	Downgrade	TD Cowen	Hold → Sell	$366
Jun-24-25	Initiated	Barclays	Equal Weight	$300
Apr-22-25	Downgrade	William Blair	Outperform → Mkt Perform
Apr-14-25	Downgrade	TD Cowen	Buy → Hold	$328
Mar-24-25	Initiated	Leerink Partners	Market Perform	$330
Oct-23-24	Downgrade	Robert W. Baird	Outperform → Neutral	$413 → $349
Oct-14-24	Initiated	Redburn Atlantic	Buy
Sep-27-24	Downgrade	UBS	Buy → Neutral	$420 → $350
Sep-25-24	Downgrade	Jefferies	Buy → Hold	$415 → $345
Aug-01-24	Initiated	Truist	Hold	$415
May-29-24	Initiated	TD Cowen	Buy	$452
May-28-24	Initiated	Mizuho	Buy	$435
Apr-23-24	Upgrade	Jefferies	Hold → Buy	$340 → $450
Mar-18-24	Initiated	Deutsche Bank	Hold	$395
Feb-15-24	Upgrade	UBS	Neutral → Buy	$282 → $452
Oct-24-23	Upgrade	Robert W. Baird	Neutral → Outperform	$270 → $289

Show Previous Ratings

Nov-24-25 10:31PM	Medpace (NASDAQ:MEDP): Strongest Q3 Results from the Drug Development Inputs & Services Group (StockStory)
05:15PM	Stock Market Roars To Key Level As Tesla, Palantir, Broadcom Jump; What To Do Now (Investor's Business Daily)
11:40AM	BTSG or MEDP: Which Is the Better Value Stock Right Now? (Zacks)
11:09AM	GE HealthCare to Acquire Intelerad for $2.3B to Boost Cloud Imaging (Zacks)
07:53AM	Should You Hold Quest Diagnostics Stock in Your Portfolio for Now? (Zacks)
08:00AM	Loading…
Nov-22-25 08:00AM	S&P 500 Retailer Leads Five Resilient Stocks After Nvidia-Led Market Sell-Off (Investor's Business Daily)
Nov-21-25 10:53AM	Veeva Systems Stock Down Despite Q3 Earnings & Revenues Top Estimates (Zacks)
10:50AM	Reasons to Hold AngioDynamics Stock in Your Portfolio for Now (Zacks)
08:20AM	Medpace (MEDP) Surged Following Better-Than-Expected Results (Insider Monkey)
08:11AM	LH Shares Gain Following Publication of New Plasma Detect MRD Data (Zacks)
Nov-20-25 09:34AM	Reasons to Add HealthEquity Stock to Your Portfolio for Now (Zacks)
09:16AM	DXCM Stock Falls Despite FDA Clearance for Dexcom Smart Basal (Zacks)
07:50AM	EMBC Q4 Preview: Product Momentum and Strategy Gains to Support Growth? (Zacks)
07:49AM	TMO Stock May Rise Post New PCR Test in Collab With Coca-Cola Partner (Zacks)
Nov-18-25 04:05PM	Why IBD Stock Of The Day Medpace, Up 78% In 2025, Is Easily Outpacing Its Peers (Investor's Business Daily)
12:45PM	Loading…
12:45PM	Medpace (MEDP) is an Incredible Growth Stock: 3 Reasons Why (Zacks)
11:39AM	BFLY Stock Down Despite Launching Compass AI to Drive POCUS Programs (Zacks)
09:31AM	Medtronic's Q2 Earnings & Revenues Beat Estimates, Stock Climbs (Zacks)
Nov-17-25 12:39PM	Ecolab Launches Integrated Cooling Platform to Support AI Data Centers (Zacks)
Nov-14-25 08:02AM	HealthEquity Rolls Out Agentic AI to Elevate Member Support Experience (Zacks)
Nov-13-25 08:46AM	Insulet Stock Up Post Q3 Earnings & Revenue Beat, Margins Expand (Zacks)
08:08AM	TFX Stock Falls Despite Q3 Earnings and Revenue Beat, '25 View Down (Zacks)
Nov-12-25 07:13AM	ALC's Q3 Earnings Beat, Revenues Miss, Stock Rises in After-Market Hours (Zacks)
Nov-11-25 07:55AM	Penumbra Stock Up Post Q3 Earnings & Revenue Beat, Margins Expand (Zacks)
07:26AM	VCYT Stock Gains on Q3 Earnings and Revenue Beat, '25 View Up (Zacks)
Nov-07-25 11:40AM	BTSG vs. MEDP: Which Stock Is the Better Value Option? (Zacks)
Nov-06-25 08:29AM	STE Stock Gains on Q2 Earnings and Revenue Beat, '26 EPS View Up (Zacks)
05:49AM	New Strong Buy Stocks for November 6th (Zacks)
Nov-05-25 12:17PM	Zimmer Biomet Q3 Earnings Top but Revenue Miss Causes Pre-Market Drop (Zacks)
11:01AM	TEM's Q3 Earnings & Revenues Beat, Stock Down in After-Market Hours (Zacks)
10:52AM	Loading…
10:52AM	TECH Stock Falls on Q1 Earnings Meet, Revenues Miss, Margins Up (Zacks)
09:22AM	CRL's Q3 Earnings Top Estimates, Revenues Decline Y/Y, Stock Falls (Zacks)
Nov-04-25 08:54AM	HSIC Stock Jumps on Q3 Earnings and Revenue Beat, '25 Outlook Up (Zacks)
08:07AM	HOLX Stock Up on Q4 Earnings & Revenue Beat, Operating Margin Expands (Zacks)
Oct-31-25 11:05AM	BFLY's Q3 Earnings Miss Estimates, Revenues Surpass, Stock Climbs (Zacks)
08:22AM	Resmed Stock Up on Q1 Earnings & Revenue Beat, Margins Expand (Zacks)
08:20AM	Medpace Holdings (MEDP) Generated Strong Results in Q3 (Insider Monkey)
Oct-30-25 09:04AM	Bio-Rad's Q3 Earnings Miss Estimates, Revenues Surpass, Stock Falls (Zacks)
Oct-29-25 09:40AM	Is Medpace (MEDP) Stock Outpacing Its Medical Peers This Year? (Zacks)
09:00AM	CVS Stock Falls Despite Q3 Earnings & Revenue Beat, '25 EPS View Up (Zacks)
01:35AM	5 Revealing Analyst Questions From Medpace's Q3 Earnings Call (StockStory)
Oct-28-25 12:00PM	Medpace (MEDP) Upgraded to Strong Buy: What Does It Mean for the Stock? (Zacks)
07:12AM	Best Momentum Stock to Buy for Oct. 28th (Zacks)
05:51AM	New Strong Buy Stocks for Oct. 28: NCNO, VRT, and More (Zacks)
Oct-27-25 08:50AM	Why Investors Need to Take Advantage of These 2 Medical Stocks Now (Zacks)
Oct-24-25 06:06PM	Analyst Report: Medpace Holdings, Inc. (Morningstar Research)
01:05PM	Why Medpace Popped 13% This Week (Motley Fool)
Oct-23-25 04:11PM	Medpace Jumps On 'Another Strong Q' That Includes A Guidance Hike (Investor's Business Daily) +9.12%
03:07PM	Medpace Holdings Inc (MEDP) Q3 2025 Earnings Call Highlights: Strong Revenue Growth and Robust ... (GuruFocus.com)
02:06PM	MEDP Q3 Deep Dive: Broad-Based Growth and Strong Pipeline Fuel Upbeat Outlook (StockStory)
11:15AM	Medpace Holdings' Good Quarter Is Another Sign Biotech Is Back (Barrons.com)
10:06AM	Biggest Market Mover Thursday: Medpace Stock Jumps On Strong Q3 Results (GuruFocus.com)
09:59AM	Medpace Rockets On 'Another Strong Q' That Includes A Guidance Hike (Investor's Business Daily)
06:17AM	Stocks Muted Before the Open With Earnings in Focus (Barchart)
Oct-22-25 05:40PM	Medpace (MEDP) Beats Q3 Earnings and Revenue Estimates (Zacks)
05:23PM	Medpace shares soar on blowout Q3 results, solid 2025 outlook (Investing.com)
05:03PM	Medpace (NASDAQ:MEDP) Beats Q3 Sales Expectations, Stock Jumps 18.5% (StockStory)
04:43PM	Medpace: Q3 Earnings Snapshot (Associated Press Finance)
04:15PM	Medpace Holdings, Inc. Reports Third Quarter 2025 Results (Business Wire)
02:35PM	Medpace Holdings, Inc. (MEDP): A Bull Case Theory (Insider Monkey)
11:40AM	SOLV or MEDP: Which Is the Better Value Stock Right Now? (Zacks)
Oct-20-25 11:08PM	Medpace (MEDP) Reports Earnings Tomorrow: What To Expect (StockStory)
Oct-17-25 10:18AM	Danaher Gears Up to Post Q3 Earnings: What Lies Ahead for the Stock? (Zacks)
Oct-16-25 06:15PM	Medpace (MEDP) Rises As Market Takes a Dip: Key Facts (Zacks)
08:19AM	Should You be Excited about Medpace Holdings' (MEDP) Prospects? (Insider Monkey)
Oct-15-25 10:00AM	Medpace (MEDP) Earnings Expected to Grow: What to Know Ahead of Next Week's Release (Zacks)
Oct-14-25 09:57AM	Robust Booking Growth Boosted Medpace Holdings (MEDP) in Q3 (Insider Monkey)
Oct-10-25 06:15PM	Medpace (MEDP) Dips More Than Broader Market: What You Should Know (Zacks) +5.22%
03:50PM	Medpace and Revvity Stocks Trade Down, What You Need To Know (StockStory)
08:50AM	How to Boost Your Portfolio with Top Medical Stocks Set to Beat Earnings (Zacks)
Oct-09-25 12:10PM	Will Medpace (MEDP) Beat Estimates Again in Its Next Earnings Report? (Zacks)
09:48AM	Brookdale Posts Strong YoY Rise in September 2025 Occupancy (Zacks)
09:40AM	Is Medpace (MEDP) Outperforming Other Medical Stocks This Year? (Zacks)
08:50AM	How to Boost Your Portfolio with Top Medical Stocks Set to Beat Earnings (Zacks)
Oct-07-25 12:30PM	Nyxoah Shares Rise on First U.S. Commercial Use of Genio System (Zacks)
Oct-06-25 10:16AM	ICCM Shares Rise as FDA Clears ProSense for Breast Cancer Treatment (Zacks)
Oct-05-25 11:32PM	Drug Development Inputs & Services Stocks Q2 Recap: Benchmarking Medpace (NASDAQ:MEDP) (StockStory)
Oct-03-25 11:40AM	SOLV vs. MEDP: Which Stock Is the Better Value Option? (Zacks)
Oct-02-25 06:15PM	Medpace (MEDP) Stock Declines While Market Improves: Some Information for Investors (Zacks)
11:36AM	Why Medpace (MEDP) Stock Is Trading Lower Today (StockStory)
09:40AM	Nike upgraded, RH downgraded: Wall Street's top analyst calls (The Fly)
09:34AM	Life science tools Q3 preview: Barclays ups Charles River, downgrades Medpace (Investing.com)
Sep-29-25 08:07AM	HTFL Gains FDA Clearance & Cigna Coverage for Next Gen Plaque Analysis (Zacks)
Sep-25-25 06:15PM	Medpace (MEDP) Dips More Than Broader Market: What You Should Know (Zacks)
12:54PM	TMDX Partners With Mercedes-Benz to Launch Organ Transport Network (Zacks)
Sep-23-25 04:05PM	Medpace Holdings, Inc. to Report Third Quarter 2025 Financial Results on October 22, 2025 (Business Wire)
01:15PM	STXS Stock Gains as Erasmus Medical Adopts Its Genesis Robotic System (Zacks)
01:11PM	Reasons to Hold Fresenius Medical Stock in Your Portfolio for Now (Zacks)
Sep-22-25 12:33PM	Stryker Expands R&D Facility in India to Boost Medtech Innovation (Zacks)
12:27PM	Reasons to Hold AngioDynamics Stock in Your Portfolio for Now (Zacks)
09:46AM	Reasons to Retain Cooper Companies Stock in Your Portfolio for Now (Zacks)
09:09AM	Take the Zacks Approach to Beat the Market: LendingTree, AutoZone, J&J in Focus (Zacks)
Sep-19-25 09:19AM	Does Medpace Holdings (MEDP) Have a Long Runway For Growth? (Insider Monkey)
07:34AM	SGHT Shares Rise on Meta-Analysis Showing OMNI's Long-Term Benefits (Zacks)
Sep-18-25 10:14AM	Here's Why You Should Hold Accuray Stock in Your Portfolio for Now (Zacks)
10:05AM	SYK Partners With Siemens Healthineers to Boost Stroke, Aneurysm Care (Zacks)
08:42AM	Avanos Medical Buys Nexus Medical to Bolster Critical Care Portfolio (Zacks)
08:41AM	Entera Bio Unveils Promising PK Data for First Oral GLP-2 Therapy (Zacks)
Sep-17-25 10:41AM	BWAY Shares Gain on FDA Nod for Accelerated Deep TMS Depression Care (Zacks)
08:51AM	CAH Strengthens Distribution With New Consumer Health Logistics Hub (Zacks)

Medpace Holdings, Inc. engages in the provision of outsourced clinical development services to the biotechnology, pharmaceutical, and medical device industries. The firm's services include medical department, clinical trial management, data-driven feasibility, study-start-up, clinical monitoring, regulatory affairs, patient recruitment and retention, medical writing, biometrics and data sciences, pharmacovigilance, core laboratory, laboratories, clinics, and quality assurance. It operates through the following geographical segments: United States, Europe, Belgium, Asia-Pacific, and Other. The company was founded by August James Troendle in 1992 and is headquartered in Cincinnati, OH.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Troendle August J.	CEO	Nov 24 '25	Sale	607.78	59,025	35,874,214	774,602	Nov 26 04:29 PM
Troendle August J.	CEO	Nov 25 '25	Sale	615.52	42,392	26,093,124	732,210	Nov 26 04:29 PM
BURWIG SUSAN E	Exec. VP, Operations	Nov 24 '25	Sale	609.15	20,000	12,183,000	27,500	Nov 26 04:22 PM
August J. Troendle	Chairman	Nov 25 '25	Proposed Sale	615.00	150,000	92,250,000		Nov 25 04:43 PM
Brady Kevin M.	CFO & Treasurer	Nov 21 '25	Option Exercise	166.73	3,000	500,190	9,000	Nov 25 04:40 PM
Brady Kevin M.	CFO & Treasurer	Nov 21 '25	Sale	590.35	3,000	1,771,050	6,000	Nov 25 04:40 PM
Troendle August J.	CEO	Nov 21 '25	Sale	592.18	21,858	12,943,870	833,627	Nov 24 04:20 PM
Troendle August J.	CEO	Nov 20 '25	Sale	598.49	6,830	4,087,687	855,485	Nov 24 04:20 PM
BURWIG SUSAN E	Officer	Nov 24 '25	Proposed Sale	609.15	20,000	12,183,035		Nov 24 02:03 PM
Brady Kevin M.	Officer	Nov 21 '25	Proposed Sale	590.35	3,000	1,771,051		Nov 21 01:43 PM
Troendle August J.	CEO	Nov 19 '25	Sale	592.07	23,862	14,127,974	862,315	Nov 20 04:14 PM
Troendle August J.	CEO	Nov 18 '25	Sale	590.84	7,191	4,248,730	886,177	Nov 20 04:14 PM
Kraft Robert O.	Director	Nov 14 '25	Option Exercise	54.99	6,472	355,895	7,305	Nov 18 05:02 PM
Kraft Robert O.	Director	Nov 14 '25	Sale	591.85	6,472	3,830,453	833	Nov 18 05:02 PM
Troendle August J.	CEO	Nov 14 '25	Sale	595.26	14,747	8,778,299	899,415	Nov 18 04:51 PM
Troendle August J.	CEO	Nov 17 '25	Sale	591.00	6,047	3,573,777	893,368	Nov 18 04:51 PM
Troendle August J.	CEO	Nov 12 '25	Sale	603.23	5,312	3,204,358	919,290	Nov 14 04:41 PM
Troendle August J.	CEO	Nov 13 '25	Sale	601.37	5,128	3,083,825	914,162	Nov 14 04:41 PM
Kraft Robert O.	Director	Nov 14 '25	Proposed Sale	591.85	6,472	3,830,434		Nov 14 04:12 PM
August J. Troendle	Chairman	Nov 12 '25	Proposed Sale	600.00	150,000	90,000,000		Nov 12 04:53 PM
BURWIG SUSAN E	Exec. VP, Operations	Nov 11 '25	Sale	605.00	18,000	10,890,000	47,500	Nov 12 10:10 AM
BURWIG SUSAN E	Officer	Nov 11 '25	Proposed Sale	605.00	18,000	10,890,000		Nov 12 07:52 AM
GEIGER JESSE J	President	Nov 05 '25	Sale	595.66	21,503	12,808,477	15,000	Nov 07 04:38 PM
GEIGER JESSE J	Officer	Nov 05 '25	Proposed Sale	595.66	21,503	12,808,442		Nov 05 04:20 PM
DAVENPORT FRED B JR	Director	Oct 30 '25	Option Exercise	54.99	6,472	355,895	9,470	Nov 03 04:46 PM
DAVENPORT FRED B JR	Director	Oct 30 '25	Sale	581.88	5,972	3,474,987	3,498	Nov 03 04:46 PM
DAVENPORT FRED B JR	Director	Oct 30 '25	Proposed Sale	581.88	5,972	3,474,993		Oct 30 10:38 AM
GEIGER JESSE J	President	Oct 27 '25	Option Exercise	166.73	19,460	3,244,566	55,963	Oct 29 05:12 PM
GEIGER JESSE J	President	Oct 29 '25	Option Exercise	166.73	3,568	594,893	40,071	Oct 29 05:12 PM
GEIGER JESSE J	President	Oct 27 '25	Sale	605.12	19,460	11,775,635	36,503	Oct 29 05:12 PM
GEIGER JESSE J	President	Oct 29 '25	Sale	585.00	3,568	2,087,280	36,503	Oct 29 05:12 PM
EWALD STEPHEN P	General Counsel & Corp. Secy.	Oct 27 '25	Option Exercise	166.73	18,230	3,039,488	28,573	Oct 29 04:58 PM
EWALD STEPHEN P	General Counsel & Corp. Secy.	Oct 27 '25	Sale	598.85	15,230	9,120,486	13,343	Oct 29 04:58 PM
BURWIG SUSAN E	Exec. VP, Operations	Oct 27 '25	Sale	605.01	2,000	1,210,020	65,500	Oct 29 04:52 PM
GEIGER JESSE J	Officer	Oct 29 '25	Proposed Sale	585.00	3,568	2,087,280		Oct 29 10:29 AM
GEIGER JESSE J	Officer	Oct 27 '25	Proposed Sale	605.12	19,460	11,775,659		Oct 27 04:08 PM
BURWIG SUSAN E	Officer	Oct 27 '25	Proposed Sale	605.01	2,000	1,210,016		Oct 27 04:07 PM
EWALD STEPHEN P	Officer	Oct 27 '25	Proposed Sale	598.85	15,230	9,120,538		Oct 27 10:30 AM
BURWIG SUSAN E	Exec. VP, Operations	Sep 26 '25	Option Exercise	107.93	10,000	1,079,300	67,500	Sep 30 04:15 PM
BURWIG SUSAN E	Exec. VP, Operations	Sep 03 '25	Sale	480.00	10,000	4,800,000	57,500	Sep 05 04:16 PM
BURWIG SUSAN E	Officer	Sep 03 '25	Proposed Sale	480.00	10,000	4,800,019		Sep 03 04:49 PM
Troendle August J.	CEO	Aug 29 '25	Sale	475.90	36,196	17,225,676	925,799	Sep 03 04:10 PM
Troendle August J.	CEO	Sep 02 '25	Sale	475.11	1,197	568,707	924,602	Sep 03 04:10 PM
Troendle August J.	CEO	Aug 27 '25	Sale	475.00	620	294,500	961,995	Aug 28 04:23 PM
BURWIG SUSAN E	Exec. VP, Operations	Aug 26 '25	Option Exercise	107.93	10,000	1,079,300	67,500	Aug 28 04:10 PM
August J. Troendle	Chairman	Aug 27 '25	Proposed Sale	475.00	38,013	18,056,018		Aug 27 05:09 PM
McCarthy Cornelius P. III	Director	Aug 19 '25	Sale	465.04	1,662	772,896	10,197	Aug 21 04:56 PM
McCarthy Cornelius P. III	Director	Aug 19 '25	Proposed Sale	465.04	1,662	772,894		Aug 19 03:00 PM
EWALD STEPHEN P	General Counsel & Corp. Secy.	Jul 28 '25	Sale	450.00	3,000	1,350,000	10,343	Jul 29 06:02 PM
BURWIG SUSAN E	Exec. VP, Operations	Jul 28 '25	Sale	450.14	7,500	3,376,050	57,500	Jul 29 05:43 PM
Troendle August J.	CEO	Jul 28 '25	Sale	451.69	48,487	21,901,093	962,615	Jul 29 05:37 PM
GEIGER JESSE J	President	Jul 24 '25	Option Exercise	107.93	41,801	4,511,582	78,304	Jul 28 05:37 PM
GEIGER JESSE J	President	Jul 24 '25	Sale	453.11	41,801	18,940,451	36,503	Jul 28 05:37 PM
Brady Kevin M.	CFO & Treasurer	Jul 24 '25	Option Exercise	57.94	12,000	695,280	18,000	Jul 28 05:08 PM
Brady Kevin M.	CFO & Treasurer	Jul 24 '25	Sale	454.23	12,000	5,450,760	6,000	Jul 28 05:08 PM
BURWIG SUSAN E	Officer	Jul 28 '25	Proposed Sale	450.14	7,500	3,376,083		Jul 28 04:50 PM
August J. Troendle	Chairman	Jul 28 '25	Proposed Sale	451.68	356,446	161,001,311		Jul 28 04:35 PM
EWALD STEPHEN P	Officer	Jul 28 '25	Proposed Sale	450.00	3,000	1,350,000		Jul 28 03:27 PM
McCarthy Cornelius P. III	Director	Jul 22 '25	Option Exercise	54.99	1,972	108,440	11,859	Jul 24 04:31 PM
Brady Kevin M.	Officer	Jul 24 '25	Proposed Sale	454.23	12,000	5,450,751		Jul 24 04:13 PM
GEIGER JESSE J	Officer	Jul 24 '25	Proposed Sale	453.11	41,801	18,940,252		Jul 24 04:09 PM
McCarthy Cornelius P. III	Director	Jul 18 '25	Option Exercise	54.99	4,500	247,455	9,887	Jul 22 04:36 PM
DAVENPORT FRED B JR	Director	Apr 24 '25	Option Exercise	57.17	4,710	269,271	4,710	Apr 28 04:39 PM
DAVENPORT FRED B JR	Director	Apr 24 '25	Sale	301.82	1,712	516,716	2,998	Apr 28 04:39 PM
DAVENPORT FRED B JR	Director	Apr 24 '25	Proposed Sale	301.82	1,712	516,716		Apr 24 02:13 PM
Troendle August J.	CEO	Mar 07 '25	Option Exercise	68.62	356,446	24,458,835	1,011,102	Mar 10 05:47 PM
EWALD STEPHEN P	General Counsel & Corp. Secy.	Feb 27 '25	Buy	326.11	2	652	13,343	Feb 28 04:39 PM
Carley Brian T	Director	Feb 24 '25	Option Exercise	42.62	8,127	346,373	30,035	Feb 26 04:18 PM
Carley Brian T	Director	Feb 24 '25	Sale	345.59	4,003	1,383,397	26,032	Feb 26 04:18 PM
Carley Brian T	Director	Feb 24 '25	Proposed Sale	345.59	4,003	1,383,385		Feb 24 12:52 PM
GEIGER JESSE J	President	Dec 06 '24	Option Exercise	32.05	15,000	480,750	36,503	Dec 10 04:24 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

Black Swan Sale

50% Off Elite

MEDP

Medpace Holdings Inc

Upgrade your FINVIZ experience